Immunoglobulins are the key effectors of the humoral immune response. Correct immunoglobulin expression, which is limited to B lymphocytes and varies during B-cell development, is critical for normal immune function. Immunoglobulin heavy chain (IgH) gene transcription has provided an unusually informative paradigm for studying mechanisms which control the expression of highly regulated mammalian genes. Our work, in conjunction with that of others, has led to the identification of DNA elements responsible for the regulation of IgH gene transcription and to the cloning and characterization of activators which bind to specific sequences within these elements. Since the components of regulated IgH transcription have been identified, it is now possible to study how these components function to control the efficiency and frequency with which RNA polymerase II initiates transcription from VH promoters. The proposed studies focus primarily but not exclusively on three families of activators which we have studied in the past--those binding E, mu-E1 and mu-E3 sites. The roles of different family members and the mechanisms by which their availability and activity are regulated during B cell development will be studied. Components of the basal transcription machinery which are targets for these activators will be identified and co-activators which may be necessary for their action will be studied. The role of DNA bending in VH promoter activity will be determined and mechanisms required for activators to work from a distant (enhancer) site will be studied. Finally, the requirement for specific activators in lymphocyte function and in the development of whole animals will be determined using gene targeting experiments. The proposed studies are the logical culmination of previous work because we now possess the molecular tools necessary to dissect individual molecular events in the regulated transcription of IgH genes. Thus, studying IgH transcription will continue to provide paradigmatic new insights into transcriptional regulation in higher organisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM029361-18
Application #
2021878
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1988-12-01
Project End
1997-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
18
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Johnson, Kristen; Angelin-Duclos, Cristina; Park, Sinae et al. (2003) Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development. Mol Cell Biol 23:2438-50
Lin, Kuo-I; Angelin-Duclos, Cristina; Kuo, Tracy C et al. (2002) Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 22:4771-80
Shaffer, A L; Lin, Kuo I; Kuo, Tracy C et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51-62
Angelin-Duclos, Cristina; Johnson, Kristen; Liao, Jerry et al. (2002) An interfering form of Blimp-1 increases IgM secreting plasma cells and blocks maturation of peripheral B cells. Eur J Immunol 32:3765-75
Rooney, J W; Calame, K L (2001) TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937. Genes Dev 15:3023-38
Calame, K L (2001) Plasma cells: finding new light at the end of B cell development. Nat Immunol 2:1103-8
Piskurich, J F; Lin, K I; Lin, Y et al. (2000) BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol 1:526-32
Lin, K I; Lin, Y; Calame, K (2000) Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol Cell Biol 20:8684-95
Berrier, A; Siu, G; Calame, K (1998) Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J Immunol 161:2267-75
Angelin-Duclos, C; Calame, K (1998) Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol Cell Biol 18:6253-64

Showing the most recent 10 out of 43 publications